Lin YC - Search Results

1

[Inhibitory effect of ginsenoside Rg3 on the tube-like structure formation in human nasopharyngeal carcinoma HNE-1 cell line in vitro].

Wang HB, Lin YC, Zeng D, Lin W, Hong CQ, Lin WZ, Chen JY. Wang HB, et al. Among authors: lin wz, lin w, lin yc. Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):739-42. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21163062 Chinese.

2

[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].

Lin YC, Lin Y, Lin W, Du CW, Wu MY, Li DR. Lin YC, et al. Among authors: lin y, lin w. Ai Zheng. 2002 Dec;21(12):1359-61. Ai Zheng. 2002. PMID: 12520748 Clinical Trial. Chinese.

3

[Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model].

Du CW, Li DR, Lin YC, Wu MY. Du CW, et al. Among authors: lin yc. Ai Zheng. 2003 Jan;22(1):21-5. Ai Zheng. 2003. PMID: 12561430 Chinese.

4

Differentiation of human nasopharyngeal carcinoma xenografts and repression of telomerase activity induced by arsenic trioxide.

Du C, Li D, Lin Y, Wu M. Du C, et al. Natl Med J India. 2004 Mar-Apr;17(2):67-70. Natl Med J India. 2004. PMID: 15141597

5

Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.

Du C, Wen B, Li D, Lin Y, Zheng Y, Peng X, Hong C, Chen J, Lin W, Hong X, Xie L, Wu M. Du C, et al. Tumori. 2006 Mar-Apr;92(2):140-8. doi: 10.1177/030089160609200210. Tumori. 2006. PMID: 16724694

6

[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].

Li JL, Zhang XR, Liu JW, Chen ZY, Lin YC, Wang YD, Chen Q, Nan KJ, Song SP, Han FC, Zhu YZ, Li LY, Zheng YH, Chu DT. Li JL, et al. Among authors: lin yc. Zhonghua Zhong Liu Za Zhi. 2006 Apr;28(4):309-12. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875636 Clinical Trial. Chinese.

7

[Relationship between radiotherapy enhancing effect of arsenic trioxide and the proliferation and apoptosis of related protein in nasopharyngeal carcinoma patients].

Lin YC, Li DR, Lin W. Lin YC, et al. Among authors: lin w. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Aug;27(8):704-7. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007. PMID: 17879533 Clinical Trial. Chinese.

8

[Establishment of a cisplatin-induced human nasopharyngeal carcinoma drug-resistant cell line and its biological characteristics].

Lin W, Li D, Lin Y, Du C, Chen J, Hong C. Lin W, et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Nov;22(21):992-4, 997. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008. PMID: 19157152 Chinese.

9

[The efficacy of vinorelbine plus cisplatin in the treatment of 48 cases of advanced non-small cell lung cancer].

Lin Y, Lin Y, Lin W, Wang H, Zeng D, Lin S, Huo X. Lin Y, et al. Zhongguo Fei Ai Za Zhi. 2005 Feb 20;8(1):51-3. doi: 10.3779/j.issn.1009-3419.2005.01.12. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21187026 Free article. Chinese.

10

Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.

Li XY, Lin YC, Huang WL, Hong CQ, Chen JY, You YJ, Li WB. Li XY, et al. Among authors: lin yc. Med Oncol. 2012 Jun;29(2):714-20. doi: 10.1007/s12032-011-9904-1. Epub 2011 Mar 24. Med Oncol. 2012. PMID: 21431960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,537 results

Search Page

Filters